本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

再鼎医药

37.00
+2.346.75%
盘后37.000.00000.00%19:30 EDT
成交量:179.79万
成交额:6,661.82万
市值:40.92亿
市盈率:-14.92
高:38.77
开:37.50
低:36.40
收:34.66
数据加载中...
2025/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/19

SEC问询函

Form CORRESP - Correspondence
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities